VISTAGEN THERAPEUTICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.48 USD | +7.08% |
|
+8.07% | -32.30% |
| 11/06 | Transcript : Vistagen Therapeutics, Inc., Q4 2024 Earnings Call, Jun 11, 2024 | |
| 11/06 | Vistagen Therapeutics, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Chart calendar Vistagen Therapeutics, Inc.
e0eba483c8ba.S5it3oiKUo_uR3AUzq1IOsqZPs9WfmHxBa7W_F5D9Og.PcrX57DLFba2KhtGpdcDCovMVaMwBFmrbsuGuiwzx6skrNSLut8a27sGKQ~a941a10a745d037b94f0c76f317affbb
Upcoming events on Vistagen Therapeutics, Inc.
Past events on Vistagen Therapeutics, Inc.
| 12/06/2024 02:30 am | Q4 2024 Earnings Call |
| 12/06/2024 01:50 am | Q4 2024 Earnings Release |
| 06/06/2024 08:30 pm | Jefferies Global Healthcare Conference |
| 29/05/2024 10:30 pm | Annual General Meeting |
| 29/05/2024 08:45 pm | American Society of Clinical Psychopharmacology Meeting - Poster Number: W78 |
| 29/05/2024 08:45 pm | American Society of Clinical Psychopharmacology Meeting - Poster Number: W96 |
| 16/05/2024 01:35 am | RBC Capital Markets Global Healthcare Conference |
| 14/04/2024 01:15 am | Anxiety and Depression Association of America Conference - Poster No: S256 |
| 14/04/2024 01:15 am | Anxiety and Depression Association of America Conference - Poster No: S125 |
| 20/03/2024 09:30 pm | Stifel CNS Day |
| 06/03/2024 09:00 pm | TD Cowen Health Care Conference |
| 14/02/2024 03:30 am | Q3 2024 Earnings Call |
| 14/02/2024 02:50 am | Q3 2024 Earnings Release |
| 14/11/2023 11:45 pm | Stifel Healthcare Conference |
| 10/11/2023 10:30 pm | CNS Summit |
| 10/11/2023 | Neuroscience Education Institute Congress - Poster No: 109 |
| 10/11/2023 | Neuroscience Education Institute Congress - Poster No: 89 |
| 10/11/2023 | Neuroscience Education Institute Congress - Poster No: 47 |
| 10/11/2023 03:30 am | Q2 2024 Earnings Call |
| 10/11/2023 03:00 am | Q2 2024 Earnings Release |
Annual results
| Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 1,09 0,88 24.19% | 1,11 1,32 -16.28% | -0,23 -0,40 43.6% | 1,06 1,07 -0.26% | 0,20 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -20,8 -21,7 4.01% | -17,9 -18,6 3.69% | -47,8 -43,2 -10.49% | -59,3 -57,1 -3.84% | -33,0 -32,4 -2.05% | -70,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,8 -21,6 3.99% | -17,9 -18,5 3.33% | -47,8 -43,2 -10.61% | -59,2 -57,1 -3.82% | -29,4 -30,1 2.42% | -67,0 |
|
Net income Million USD | Released Forecast Spread | -22,0 -22,7 3.08% | -42,3 -19,5 -116.91% | -48,7 -44,0 -10.75% | -59,2 -57,1 -3.83% | -29,4 -30,1 2.41% | -67,0 |
|
EPS USD | Released Forecast Spread | -15,0 -14,9 -1.01% | -14,7 -6,53 -125.29% | -7,50 -6,53 -14.94% | -8,51 -8,40 -1.31% | -1,52 -1,60 4.85% | -2,18 |
| Announcement Date | 29/06/20 | 29/06/21 | 23/06/22 | 28/06/23 | 11/06/24 | - |
Quarterly results
| Fiscal Period | März | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,04 0,25 -84.68% | 0,31 0,24 29.95% | -0,89 0,21 -531.79% | 0,18 0,31 -42.06% | 0,18 0,00 - | 0,18 0,00 - | 0,28 0,00 - | 0,41 0,54 -24.44% | 0,20 0,20 -2.69% | 0,30 | 0,10 | 0,10 | 0,10 |
|
EBIT Million USD | Released Forecast Spread | -16,7 -12,2 -37.35% | -19,8 -16,0 -23.88% | -17,5 -13,6 -28.81% | -9,77 -14,2 31.44% | -12,2 -10,0 -21.83% | -7,00 -6,73 -3.96% | -6,78 -7,37 7.95% | -7,88 -8,38 5.88% | -11,4 -10,7 -6.52% | -13,3 | -16,8 | -19,4 | -20,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,7 -12,1 -37.91% | -19,8 -15,9 -24.66% | -17,5 -13,6 -28.78% | -9,76 -14,2 31.46% | -12,2 -10,0 -21.71% | -6,90 -6,73 -2.52% | -6,59 -7,37 10.57% | -6,35 -8,30 23.53% | -9,70 -10,2 5.3% | -12,4 | -15,9 | -18,6 | -20,1 |
|
Net income Million USD | Released Forecast Spread | -16,7 -12,2 -36.76% | -19,8 -15,9 -24.7% | -17,5 -13,6 -28.78% | -9,76 -14,2 31.46% | -12,2 -10,0 -21.71% | -6,90 -6,73 -2.56% | -6,59 -7,37 10.57% | -6,35 -8,30 23.53% | -9,79 -10,2 4.4% | -12,4 | -15,9 | -18,6 | -20,1 |
|
EPS USD | Released Forecast Spread | -2,70 -1,73 -56.52% | -3,00 -2,40 -25% | -2,40 -2,00 -20% | -1,50 -2,10 28.57% | -0,84 -1,50 43.78% | -0,94 -0,86 -9.3% | -0,66 -0,68 2.94% | -0,22 -0,30 27.27% | -0,25 -0,36 31.03% | -0,41 | -0,52 | -0,60 | -0,66 |
| Announcement Date | 23/06/22 | 11/08/22 | 10/11/22 | 07/02/23 | 28/06/23 | 10/08/23 | 09/11/23 | 13/02/24 | 11/06/24 | - | - | - | - |
More events
Past sector events for Vistagen Therapeutics, Inc.
| 05/06/2024 01:21 pm | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 16/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 05:35 pm | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VTGN Stock
- Calendar Vistagen Therapeutics, Inc.
